| 摘要 |
<p>A botulinum toxin, for example botulinum toxin type A, is useful in the preparation of a pharmaceutical composition for treating at least one symptom of unstable bladder, such as urinary retention. The composition may be provided in a form suitable for administration into the urinary tract of a patient, for example to the bladder of a patient.</p><p><Paragraphs id="pa02" num="0002" xmlns:base="http://www.sipo.gov.cn/XMLSchema/base">The composition may be formulated in a pharmaceutically acceptable formulation selected from a liquid, a powder, a cream, an emulsion, a pill, a troche, a suppository, a suspension, a solution or an injectable composition.</p> |
